Bridge HCV Trainings for Addiction and HCV Treatment Centers

Below is a description of the Bridge HCV training offered in collaboration with Exchange CME

ADDICTION CENTERS

Credit: 1.0 hour inclusive of CME/CNE/CE credit provided by Purdue University.

Audience: 10-15 participants inclusive of clinical as well as non-clinical staff – social workers, counselors, advisors, and advocates.

Agenda Topics: (Dr. Norton)

• Understanding the need for referral and linkage to HCV care
• The national and local epidemiologic imperative: HCV treatment as prevention within PWID populations
• Barriers to treatment of HCV-positive PWID: addressing clinical assumptions regarding eligibility and prescribing limitations
• Updates on clinical evidence for the feasibility and success of treating HCV-positive PWID
• A holistic approach to harm reduction
• Real-world integration: optimizing collaboration with HCV care specialists

HCV TREATMENT CENTERS

 Credit: This is a two-part education – each educational session is 1.0 hour (total of 2.0 hours of CME/CNE/CE credit) and scheduled about a week or two apart.

Audience:  10-15 participants inclusive of MDs, PhDs RNs, PAs, NPs, pharmacists, social workers, counselors as well as your non-clinical staff who support your patients.

 Agendas

Part 1: Keys to Successful Treatment of HCV in People Who Inject Drugs (Dr. Norton)

• The national and local epidemiologic imperative: HCV treatment as prevention within PWID populations
• Barriers to treatment of HCV-positive PWID: addressing clinical assumptions regarding eligibility and prescribing limitations
• Updates on clinical evidence for the feasibility and success of treating HCV-positive PWID
• Real-world integration: Optimizing sustained virologic response (SVR) and reinfection prevention in PWID

Part 2: Anatomy of Addiction (Includes a Harm Reduction Specialist with Dr. Norton)

• The direct risks and clinical ramifications of injection practices
• A holistic approach to harm reduction
• The HCV treater’s role in overdose-death prevention
• Educating the patient and the provider
• Optimizing interdisciplinary collaboration in support of HCV-positive PWID

For more information, contact

Mara Simpson

Vice President, Account Services

Integritas Communications Group

Cell: 719-648-8204

msimpson@integritasgrp.com

Last Updated on May 11, 2020 by HepFree NYC